EPICS Congress Coverage: SABCS 2020 – Focus on Breast Cancer

Expert perspectives and strategic insights on the latest therapeutic developments in breast cancer treatment.

December 14, 2020


Adam Brufsky, MD, PhD

UPMC Hillman Cancer Center, PA, US

Faculty Members

Nadia Harbeck, MD, PhD
Ludwig-Maximilians-University of Munich – Breast Center, Munich, Germany

Peter A. Kaufman, MD
University of Vermont, VT, US

Miguel Martin, MD, PhD
Hospital General Universitario Gregorio Marañón, Madrid, Spain

Joyce A. O’Shaughnessy, MD
Texas Oncology-Baylor Charles A. Sammons Cancer Center, TX, US

Mark Pegram, MD
Stanford Cancer Institute, CT, US

Hope Rugo, MD
University of California San Francisco Comprehensive Cancer Center, CA, US

Sample Report

Start discovering the insights

View Report


The report was based on the following topics

  • CDK4/6 Inhibitors and Other Targeted Agents for ER+ Breast Cancer
  • Chemotherapy and Endocrine Therapy for ER+ Breast Cancer
  • New Therapeutic Approaches for Early Stage and Metastatic HER2+ Breast Cancer
  • Immunotherapy and Cytotoxic Therapies for TNBC
  • Other Novel Therapeutic Approaches for Breast Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.